2,740 Shares in Encompass Health Co. (NYSE:EHC) Purchased by Everence Capital Management Inc.

Everence Capital Management Inc. bought a new stake in shares of Encompass Health Co. (NYSE:EHC) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 2,740 shares of the company’s stock, valued at approximately $253,000.

A number of other large investors also recently added to or reduced their stakes in the business. UMB Bank n.a. raised its stake in shares of Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after buying an additional 252 shares during the last quarter. V Square Quantitative Management LLC raised its position in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after acquiring an additional 140 shares during the last quarter. Avior Wealth Management LLC acquired a new position in shares of Encompass Health in the 3rd quarter valued at $40,000. Benjamin F. Edwards & Company Inc. boosted its position in shares of Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after purchasing an additional 198 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Encompass Health during the second quarter worth $58,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. UBS Group raised their target price on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. KeyCorp boosted their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Royal Bank of Canada boosted their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Finally, Barclays lifted their target price on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Encompass Health presently has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $91.52 on Wednesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a market cap of $9.22 billion, a price-to-earnings ratio of 22.11, a price-to-earnings-growth ratio of 1.30 and a beta of 0.89. The stock’s 50-day moving average is $98.69 and its 200-day moving average is $93.62. Encompass Health Co. has a one year low of $67.12 and a one year high of $104.55.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the previous year, the business posted $0.86 EPS. The business’s quarterly revenue was up 11.9% compared to the same quarter last year. Equities analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.74%. Encompass Health’s payout ratio is currently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.